CHARM Therapeutics
charmtx.comLocations
United Kingdom · London, UK · Mile End, London, UK · Kingston Vale, London SW15, UK
industry
Artificial Intelligence (AI) · Biotechnology · Life Science · Therapeutics
Size
11 - 50 employees
Stage
Series B
founded in
2021
Socials
About
Charm Therapeutics designs and develops a new generation of small-molecule therapeutics that target the interaction between menin and the KMT2A protein, a key driver of Acute Myeloid Leukemia (AML), using its proprietary AI-powered platform called DragonFold. The company’s lead program is a menin inhibitor optimized to maintain activity against all known clinical resistance mutations while minimizing safety and drug-interaction risks. Charm Therapeutics employs protein-ligand co-folding intelligence to inform molecular design, advancing its pipeline from preclinical stages toward the clinic.
Open jobs at CHARM Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.